Covid 19 Antibody Study
- All
- News
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
- Wednesday September 15, 2021
- World News | Asian News International
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
- www.ndtv.com
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
- Thursday August 12, 2021
- World News | Reuters
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
- www.ndtv.com
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
- Wednesday September 15, 2021
- World News | Asian News International
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
- www.ndtv.com
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
- Thursday August 12, 2021
- World News | Reuters
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
- www.ndtv.com